CompletedNCT02220790
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Studying Invasive candidiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Duke University
- Principal Investigator
- William J Steinbach, MDDuke University
- Enrollment
- 515 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2020
Study locations (22)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Children's Hospital of Orange County, Orange, California, United States
- Rady Children's Hospital, San Diego, California, United States
- UCSF Benioff Children's Hospital, San Francisco, California, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- Ann and Robert Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Children's Mercy, Kansas City, Missouri, United States
- Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
- New York-Presbyterian Phyllis and David Komansky Center for Children's Health, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- Cincinnati Children's Medical Center, Cincinnati, Ohio, United States
- Cleveland Clinic Children's, Cleveland, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- +7 more locations on ClinicalTrials.gov
Collaborators
Children's Hospital of Philadelphia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02220790 on ClinicalTrials.govOther trials for Invasive candidiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT05421858A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.Basilea Pharmaceutica
- RECRUITINGPHASE2NCT06194201A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisFujian Shengdi Pharmaceutical Co., Ltd.
- RECRUITINGNCT06456151Invasive Candidiasis in Critical CareUniversity Hospital Ostrava
- RECRUITINGNANCT05763251Comparison of Uncomplicated Candidemia Therapy Duration in ChildrenArkansas Children's Hospital Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT04368559Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationMundipharma Research Limited
- RECRUITINGNANCT03538912Early Discontinuation of Empirical Antifungal Therapy and BiomarkersUniversity Hospital, Lille